Robert McRae's most recent trade in Palisade Bio Inc was a trade of 655 Common Stock, par value $0.01 done . Disclosure was reported to the exchange on April 3, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Palisade Bio Inc | Robert McRae | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 655 | 895 | - | 0 | Common Stock, par value $0.01 | |
Palisade Bio Inc | Robert McRae | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 655 | 1,963 | - | - | Restricted Stock Units | |
Palisade Bio Inc | Robert McRae | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.00 per share. | 03 Apr 2023 | 270 | 625 | - | 2 | 540 | Common Stock, par value $0.01 |